Peter R. Martin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter R. Martin has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Mary S. Dietrich
4 shared publicationsMark K. Nickel
3 shared publicationsMitchell H. Parks
Vanderbilt Addiction Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA
3 shared publicationsRonald R. Price
2 shared publications- Susan M. Stine
Department of Psychiatry and Behavioral Neurosciences Wayne State University Detroit MI USA
2 shared publications A. J. Reid Finlayson
Department of Psychiatry, Vanderbilt University, Nashville, TN, USA
1 shared publication
Latest Publications
- Open Access
- 1 April 2018
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 185, 40-49
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes
- 1 April 2018
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 185, 40-49
Open AccessPrenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes
- 17 July 2015
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- Vol. 41 (5) , 367-370
Opioid use disorder during pregnancy in Tennessee: expediency vs. science
Methadone and buprenorphine are highly effective and commonly prescribed for the treatment of opioid use disorder. Both medications are also efficacious for the treatment of pregnant women with this disorder. In one third of states, however, Medicaid reimbursement will cover the cost of buprenorphine, but not methadone, to treat opioid use disorder in pregnant women. This commentary will explore the clinical and policy rational and consequences of this policy, with the opinion that this approach is guided by political expediency rather than sound clinical research. The commentary will focus on the pharmacological management of prescription opioid dependence during pregnancy in Tennessee, one of the states that restrict Medicaid coverage of pregnant women to buprenorphine. Tennessee is also relevant in that this state ranks second nationally in the rate of prescriptions written for opioid pain relievers; in contrast to injection opioid use in urban populations, opioid addiction in rural and southeastern regions of the US is characterized by use of non-injection prescription opioids. Until recently, most research-based recommendations for the management of opioid use disorder during pregnancy have derived from studies of women using opioids intravenously. The lack of research in non-injection opioid-using pregnant women may partially explain why policy rather than scientific evidence guides Medicaid reimbursement. It is hoped that future research in pregnant women addicted to prescription opioids will clarify which opioid addicted pregnant women have better outcomes with buprenorphine or methadone treatment and these findings, in turn, will inform Medicaid reimbursement.
- 17 July 2015
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- Vol. 41 (5) , 367-370
Opioid use disorder during pregnancy in Tennessee: expediency vs. science
Methadone and buprenorphine are highly effective and commonly prescribed for the treatment of opioid use disorder. Both medications are also efficacious for the treatment of pregnant women with this disorder. In one third of states, however, Medicaid reimbursement will cover the cost of buprenorphine, but not methadone, to treat opioid use disorder in pregnant women. This commentary will explore the clinical and policy rational and consequences of this policy, with the opinion that this approach is guided by political expediency rather than sound clinical research. The commentary will focus on the pharmacological management of prescription opioid dependence during pregnancy in Tennessee, one of the states that restrict Medicaid coverage of pregnant women to buprenorphine. Tennessee is also relevant in that this state ranks second nationally in the rate of prescriptions written for opioid pain relievers; in contrast to injection opioid use in urban populations, opioid addiction in rural and southeastern regions of the US is characterized by use of non-injection prescription opioids. Until recently, most research-based recommendations for the management of opioid use disorder during pregnancy have derived from studies of women using opioids intravenously. The lack of research in non-injection opioid-using pregnant women may partially explain why policy rather than scientific evidence guides Medicaid reimbursement. It is hoped that future research in pregnant women addicted to prescription opioids will clarify which opioid addicted pregnant women have better outcomes with buprenorphine or methadone treatment and these findings, in turn, will inform Medicaid reimbursement.
- 1 January 2014
- Published by Elsevier
- Vol. 125, 573-588
Co-occurring psychiatric disorders and alcoholism
- 1 January 2014
- Published by Elsevier
- Vol. 125, 573-588
Co-occurring psychiatric disorders and alcoholism
- Open Access
- 1 January 2014
- Published by Elsevier in Developmental Cognitive Neuroscience
- Vol. 7, 43-52
Caudate responses to reward anticipation associated with delay discounting behavior in healthy youth
- 1 January 2014
- Published by Elsevier in Developmental Cognitive Neuroscience
- Vol. 7, 43-52
Open AccessCaudate responses to reward anticipation associated with delay discounting behavior in healthy youth
- 25 May 2010
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 34 (6) , 1098-1109
Recruitment of Additional Brain Regions to Accomplish Simple Motor Tasks in Chronic Alcohol‐Dependent Patients
Background: Chronic alcohol‐dependent patients (ALC) exhibit neurocognitive impairments attributed to alcohol‐induced fronto‐cerebellar damage. Deficits are typically found in complex task performance, whereas simple tasks may not be significantly compromised, perhaps because of little understood compensatory changes.Methods: We compared finger tapping with either hand at externally paced (EP) or maximal self‐paced (SP) rates and concomitant brain activation in ten pairs of right‐hand dominant, age‐, and gender‐matched, severe, uncomplicated ALC and normal controls (NC) using functional magnetic resonance imaging (fMRI).Results: Mean tapping rates were not significantly different in ALC and NC for either task, but SP tapping variances were greater in ALC for both hands. SP tapping was more rapid with dominant hand (DH) than non‐dominant hand (NDH) for both groups. EP and SP tapping with the non‐dominant hand demonstrated significantly more activation in ALC than NC in the pre and postcentral gyri, inferior frontal gyrus, inferior parietal lobule, and the middle temporal gyrus. Areas activated only by ALC (not at all by NC) during NDH tapping included the inferior frontal gyrus, middle temporal gyrus, and postcentral gyrus. There were no significant group activation differences with DH tapping. No brain regions activated more in NC than ALC. SP tapping in contrast to EP activated fronto‐cerebellar networks in NC, including postcentral gyrus, anterior cingulate, and the anterior lobe and vermis of the cerebellum, but only parietal precuneus in ALC.Conclusions: These findings with NDH finger tapping support previous reports of neurocognitive inefficiencies in ALC. Inferior frontal activation with EP in ALC, but not in NC, suggests engagement of regions needed for planning, organization, and impulse regulation; greater contralateral parietal lobe activation with SP in ALC may reflect right hemispheric impairments in visuospatial performance. Contrasting brain activation during SP and EP suggests that ALC may not have enlisted a fronto‐cerebellar network as did NC but rather employed a higher order planning mode by recruiting parietal lobe functions to attain normal mean finger tapping rates. Elucidation of the compensatory neural mechanisms that allow near normal performance by ALC on simple tasks can inform functional rehabilitation of patients in recovery.
- 25 May 2010
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 34 (6) , 1098-1109
Recruitment of Additional Brain Regions to Accomplish Simple Motor Tasks in Chronic Alcohol‐Dependent Patients
Background: Chronic alcohol‐dependent patients (ALC) exhibit neurocognitive impairments attributed to alcohol‐induced fronto‐cerebellar damage. Deficits are typically found in complex task performance, whereas simple tasks may not be significantly compromised, perhaps because of little understood compensatory changes.Methods: We compared finger tapping with either hand at externally paced (EP) or maximal self‐paced (SP) rates and concomitant brain activation in ten pairs of right‐hand dominant, age‐, and gender‐matched, severe, uncomplicated ALC and normal controls (NC) using functional magnetic resonance imaging (fMRI).Results: Mean tapping rates were not significantly different in ALC and NC for either task, but SP tapping variances were greater in ALC for both hands. SP tapping was more rapid with dominant hand (DH) than non‐dominant hand (NDH) for both groups. EP and SP tapping with the non‐dominant hand demonstrated significantly more activation in ALC than NC in the pre and postcentral gyri, inferior frontal gyrus, inferior parietal lobule, and the middle temporal gyrus. Areas activated only by ALC (not at all by NC) during NDH tapping included the inferior frontal gyrus, middle temporal gyrus, and postcentral gyrus. There were no significant group activation differences with DH tapping. No brain regions activated more in NC than ALC. SP tapping in contrast to EP activated fronto‐cerebellar networks in NC, including postcentral gyrus, anterior cingulate, and the anterior lobe and vermis of the cerebellum, but only parietal precuneus in ALC.Conclusions: These findings with NDH finger tapping support previous reports of neurocognitive inefficiencies in ALC. Inferior frontal activation with EP in ALC, but not in NC, suggests engagement of regions needed for planning, organization, and impulse regulation; greater contralateral parietal lobe activation with SP in ALC may reflect right hemispheric impairments in visuospatial performance. Contrasting brain activation during SP and EP suggests that ALC may not have enlisted a fronto‐cerebellar network as did NC but rather employed a higher order planning mode by recruiting parietal lobe functions to attain normal mean finger tapping rates. Elucidation of the compensatory neural mechanisms that allow near normal performance by ALC on simple tasks can inform functional rehabilitation of patients in recovery.
- 4 March 2009
- Published by Wiley in The American Journal on Addictions
- Vol. 18 (2) , 148-156
Psychopharmacologic Management of Opioid‐Dependent Women during Pregnancy
Illicit drug use during pregnancy presents complex clinical challenges, including reducing drug use and treating psychiatric disorders. Pharmacologic treatment of psychiatric disorders in a pregnant woman requires an evaluation of the balance between potential clinical benefit and the risk of potential neonatal consequences. This study describes psychiatric symptoms in 111 opioid‐dependent pregnant women and their prescribed psychotropic medications. Hypomania, generalized anxiety disorder and depression were the most common disorders for which psychiatric symptoms were endorsed. Over half of women studied were prescribed some form of psychoactive medication during pregnancy. Pharmacologic vs. non‐pharmacologic treatment approaches in this patient population are discussed.
- 4 March 2009
- Published by Wiley in The American Journal on Addictions
- Vol. 18 (2) , 148-156
Psychopharmacologic Management of Opioid‐Dependent Women during Pregnancy
Illicit drug use during pregnancy presents complex clinical challenges, including reducing drug use and treating psychiatric disorders. Pharmacologic treatment of psychiatric disorders in a pregnant woman requires an evaluation of the balance between potential clinical benefit and the risk of potential neonatal consequences. This study describes psychiatric symptoms in 111 opioid‐dependent pregnant women and their prescribed psychotropic medications. Hypomania, generalized anxiety disorder and depression were the most common disorders for which psychiatric symptoms were endorsed. Over half of women studied were prescribed some form of psychoactive medication during pregnancy. Pharmacologic vs. non‐pharmacologic treatment approaches in this patient population are discussed.
- 17 September 2008
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 32 (10) , 1799-1806
Coffee and Cigarette Consumption and Perceived Effects in Recovering Alcoholics Participating in Alcoholics Anonymous in Nashville, Tennessee
Background: Alcoholics Anonymous (AA) members represent an important and relatively understudied population for improving our understanding of alcohol dependence recovery as over 1 million Americans participate in the program. Further insight into coffee and cigarette use by these individuals is necessary given AA members’ apparent widespread consumption and the recognized health consequences and psychopharmacological actions of these substances.Methods: Volunteers were sought from all open‐AA meetings in Nashville, TN during the summer of 2007 to complete a questionnaire (n = 289, completion rate = 94.1%) including timeline followback for coffee, cigarette, and alcohol consumption; the Alcoholics Anonymous Affiliation Scale; coffee consumption and effects questions; the Fagerstrom Test for Nicotine Dependence (FTND); and the Smoking Effects Questionnaire.Results: Mean (±SD) age of onset of alcohol consumption was 15.4 ± 4.2 years and mean lifetime alcohol consumption was 1026.0 ± 772.8 kg ethanol. Median declared alcohol abstinence was 2.1 years (range: 0 days to 41.1 years) and median lifetime AA attendance was 1000.0 meetings (range: 4 to 44,209 meetings); average AA affiliation score was 7.6 ± 1.5. Most (88.5%) individuals consumed coffee and approximately 33% of coffee consumers drank more than 4 cups per day (M = 3.9 ± 3.9). The most common self‐reported reasons for coffee consumption and coffee‐associated behavioral changes were related to stimulatory effects. More than half (56.9%) of individuals in AA smoked cigarettes. Of those who smoked, 78.7% consumed at least half a pack of cigarettes per day (M = 21.8 ± 12.3). Smokers’ FTND scores were 5.8 ± 2.4; over 60% of smokers were highly or very highly dependent. Reduced negative affect was the most important subjective effect of smoking.Conclusions: A greater proportion of AA participants drink coffee and smoke cigarettes in larger per capita amounts than observed in general U.S. populations. The effects of these products as described by AA participants suggest significant stimulation and negative affect reduction. Fundamental knowledge of the quantitative and qualitative aspects of coffee and cigarette consumption among AA members will enable future research to discern their impact on alcohol abstinence and recovery.
- 17 September 2008
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 32 (10) , 1799-1806
Coffee and Cigarette Consumption and Perceived Effects in Recovering Alcoholics Participating in Alcoholics Anonymous in Nashville, Tennessee
Background: Alcoholics Anonymous (AA) members represent an important and relatively understudied population for improving our understanding of alcohol dependence recovery as over 1 million Americans participate in the program. Further insight into coffee and cigarette use by these individuals is necessary given AA members’ apparent widespread consumption and the recognized health consequences and psychopharmacological actions of these substances.Methods: Volunteers were sought from all open‐AA meetings in Nashville, TN during the summer of 2007 to complete a questionnaire (n = 289, completion rate = 94.1%) including timeline followback for coffee, cigarette, and alcohol consumption; the Alcoholics Anonymous Affiliation Scale; coffee consumption and effects questions; the Fagerstrom Test for Nicotine Dependence (FTND); and the Smoking Effects Questionnaire.Results: Mean (±SD) age of onset of alcohol consumption was 15.4 ± 4.2 years and mean lifetime alcohol consumption was 1026.0 ± 772.8 kg ethanol. Median declared alcohol abstinence was 2.1 years (range: 0 days to 41.1 years) and median lifetime AA attendance was 1000.0 meetings (range: 4 to 44,209 meetings); average AA affiliation score was 7.6 ± 1.5. Most (88.5%) individuals consumed coffee and approximately 33% of coffee consumers drank more than 4 cups per day (M = 3.9 ± 3.9). The most common self‐reported reasons for coffee consumption and coffee‐associated behavioral changes were related to stimulatory effects. More than half (56.9%) of individuals in AA smoked cigarettes. Of those who smoked, 78.7% consumed at least half a pack of cigarettes per day (M = 21.8 ± 12.3). Smokers’ FTND scores were 5.8 ± 2.4; over 60% of smokers were highly or very highly dependent. Reduced negative affect was the most important subjective effect of smoking.Conclusions: A greater proportion of AA participants drink coffee and smoke cigarettes in larger per capita amounts than observed in general U.S. populations. The effects of these products as described by AA participants suggest significant stimulation and negative affect reduction. Fundamental knowledge of the quantitative and qualitative aspects of coffee and cigarette consumption among AA members will enable future research to discern their impact on alcohol abstinence and recovery.
- 1 May 2008
- Published by SAGE Publications in Journal of Pharmacy Technology
- Vol. 24 (3) , 149-153
Oxcarbazepine for Treatment of Posttraumatic Stress Disorder and Alcohol Dependence: A Case Series
Objective: To report 2 cases that examine the use of oxcarbazepine as treatment for individuals with posttraumatic stress disorder (PTSD) and comorbid alcohol dependence. Case Summaries: A 59-year-old male with a past psychiatric history significant for PTSD and alcohol dependence underwent alcohol detoxification and was subsequently prescribed oxcarbazepine 300 mg twice daily, which was titrated to 600 mg twice daily prior to discharge. He experienced significant reduction in PTSD symptoms including anxiety, nightmares, flashbacks, racing thoughts, and avoidance behaviors. Over time, he also experienced a reduction in alcohol cravings and decreased daily alcohol intake. A 62-year-old male with a past psychiatric history of PTSD and alcohol dependence was treated in the outpatient clinic. He experienced almost complete resolution of PTSD symptoms and any craving for alcohol within 4 months of starting oxcarbazepine treatment, which was initiated at 150 mg twice daily and increased to 600 mg/day during that time. Discussion: Both patients appeared to receive excellent symptomatic relief from their PTSD symptoms. Recurring symptoms, including nightmares and flashbacks, seemed to be particularly responsive to the treatment. Additionally, in both cases, it is possible that oxcarbazepine had a secondary beneficial effect by decreasing alcohol cravings, although this was not formally measured. Conclusions: Our experience with these patients suggests that oxcarbazepine could be an effective treatment for the symptoms of PTSD and may decrease alcohol cravings and consumption in patients with co-occurring alcohol dependence. Controlled studies examining the effectiveness of oxcarbazepine for treatment of patients with PTSD, including those with complicating alcohol dependence, are warranted.
- 1 May 2008
- Published by SAGE Publications in Journal of Pharmacy Technology
- Vol. 24 (3) , 149-153
Oxcarbazepine for Treatment of Posttraumatic Stress Disorder and Alcohol Dependence: A Case Series
Objective: To report 2 cases that examine the use of oxcarbazepine as treatment for individuals with posttraumatic stress disorder (PTSD) and comorbid alcohol dependence. Case Summaries: A 59-year-old male with a past psychiatric history significant for PTSD and alcohol dependence underwent alcohol detoxification and was subsequently prescribed oxcarbazepine 300 mg twice daily, which was titrated to 600 mg twice daily prior to discharge. He experienced significant reduction in PTSD symptoms including anxiety, nightmares, flashbacks, racing thoughts, and avoidance behaviors. Over time, he also experienced a reduction in alcohol cravings and decreased daily alcohol intake. A 62-year-old male with a past psychiatric history of PTSD and alcohol dependence was treated in the outpatient clinic. He experienced almost complete resolution of PTSD symptoms and any craving for alcohol within 4 months of starting oxcarbazepine treatment, which was initiated at 150 mg twice daily and increased to 600 mg/day during that time. Discussion: Both patients appeared to receive excellent symptomatic relief from their PTSD symptoms. Recurring symptoms, including nightmares and flashbacks, seemed to be particularly responsive to the treatment. Additionally, in both cases, it is possible that oxcarbazepine had a secondary beneficial effect by decreasing alcohol cravings, although this was not formally measured. Conclusions: Our experience with these patients suggests that oxcarbazepine could be an effective treatment for the symptoms of PTSD and may decrease alcohol cravings and consumption in patients with co-occurring alcohol dependence. Controlled studies examining the effectiveness of oxcarbazepine for treatment of patients with PTSD, including those with complicating alcohol dependence, are warranted.
- 19 October 2006
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 355 (16) , 1743-1745
Book Review Neurobiology of Addiction By George F. Koob and Michel Le Moal. 490 pp., illustrated. San Diego, CA, Elsevier Academic Press, 2006. $129. 0-12-419239-4
The front cover of this book includes a reproduction of Pablo Picasso's The Absinthe Drinker — an appropriate beginning to a compelling work that spans the spectrum from molecules to the mind and behavior. In the painting, a middle-aged woman sits at a table, her upper body tightly bound by her right arm, which crosses her body in a contorted fashion and restrains her left arm. Her right hand, disproportionately large as compared with the rest of her body, seems to hold her back from reaching out for a glistening bottle and a waiting glass placed on the table before her. Deep in thought, her mouth taut, while the position of her left hand puts her in a pose reminiscent of Auguste Rodin's The Thinker, she appears intense, perhaps even sad, as she contemplates the bottle and glass. I believe that this portrait of profound human anguish and ambivalence encapsulates the essence of the book it introduces to the reader — desire intermixed with, and in intense conflict with, insurmountable and out-of-control suffering — specifically, the human condition of addiction. How can addicts, who on the surface may appear like the rest of us, continue to reach for that bottle, all the while knowing that when they are intoxicated their actions shame themselves, hurt those they love, and destroy their bodies and their souls?
- 19 October 2006
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 355 (16) , 1743-1745
Book Review Neurobiology of Addiction By George F. Koob and Michel Le Moal. 490 pp., illustrated. San Diego, CA, Elsevier Academic Press, 2006. $129. 0-12-419239-4
The front cover of this book includes a reproduction of Pablo Picasso's The Absinthe Drinker — an appropriate beginning to a compelling work that spans the spectrum from molecules to the mind and behavior. In the painting, a middle-aged woman sits at a table, her upper body tightly bound by her right arm, which crosses her body in a contorted fashion and restrains her left arm. Her right hand, disproportionately large as compared with the rest of her body, seems to hold her back from reaching out for a glistening bottle and a waiting glass placed on the table before her. Deep in thought, her mouth taut, while the position of her left hand puts her in a pose reminiscent of Auguste Rodin's The Thinker, she appears intense, perhaps even sad, as she contemplates the bottle and glass. I believe that this portrait of profound human anguish and ambivalence encapsulates the essence of the book it introduces to the reader — desire intermixed with, and in intense conflict with, insurmountable and out-of-control suffering — specifically, the human condition of addiction. How can addicts, who on the surface may appear like the rest of us, continue to reach for that bottle, all the while knowing that when they are intoxicated their actions shame themselves, hurt those they love, and destroy their bodies and their souls?
- 25 May 2006
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (21) , 2301-2302
Book Review Cell Biology of Addiction Edited by Bertha K. Madras, Christine M. Colvis, Jonathan D. Pollock, Joni L. Rutter, David Shurtleff, and Mark von Zastrow. 465 pp., illustrated. Cold Spring Harbor, N.Y., Cold Spring Harbor Laboratory Press, 2006. $125. 0-87969-753-9
Book Review from The New England Journal of Medicine — Book Review
- 25 May 2006
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (21) , 2301-2302
Book Review Cell Biology of Addiction Edited by Bertha K. Madras, Christine M. Colvis, Jonathan D. Pollock, Joni L. Rutter, David Shurtleff, and Mark von Zastrow. 465 pp., illustrated. Cold Spring Harbor, N.Y., Cold Spring Harbor Laboratory Press, 2006. $125. 0-87969-753-9
Book Review from The New England Journal of Medicine — Book Review